Repercusión del remodelado inverso del ventrículo izquierdo en la respuesta clínica a la terapia de resincronización cardíaca

Strickberger, 2005, Circulation, 111, 2146, 10.1161/01.CIR.0000161276.09685.4A Auricchio, 2002, Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay, J Am Coll Cardiol, 39, 2026, 10.1016/S0735-1097(02)01895-8 Abraham, 2002, Cardiac resynchronization in chronic heart failure, N Engl J Med, 346, 1845, 10.1056/NEJMoa013168 Young, 2003, Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial, JAMA, 289, 2685, 10.1001/jama.289.20.2685 Cleland, 2005, The effect of cardiac resynchronization on morbidity and mortality in heart failure, N Engl J Med, 352, 1539, 10.1056/NEJMoa050496 Cazeau, 2001, Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay, N Engl J Med, 344, 873, 10.1056/NEJM200103223441202 Bristow, 2004, Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, 2140, 10.1056/NEJMoa032423 Ypenburg, 2009, Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular. Reverse remodeling at midterm follow-up, J Am Coll Cardiol, 53, 483, 10.1016/j.jacc.2008.10.032 Schiller, 1989, Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, subcommittee on quantification of two-dimensional echocardiograms, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Enríquez-Sarano, 1995, Effective mitral regurgitant orifice area: Clinical use and pitfalls of the proximal isovelocity surface area method, J Am Coll Cardiol, 25, 703, 10.1016/0735-1097(94)00434-R Yu, 2005, Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy, Circulation, 112, 1580, 10.1161/CIRCULATIONAHA.105.538272 Abraham, 2002, Cardiac resynchronization in chronic heart failure, N Engl J Med, 346, 1845, 10.1056/NEJMoa013168 Bax, 2005, Cardiac resynchronization therapy part 1-issues before device implantation, J Am Coll Cardiol, 46, 2153, 10.1016/j.jacc.2005.09.019 Ypenburg, 2008, Optimal left ventricular lead position predicts reverse remodeling and survival alter cardiac resynchronization therapy, J Am Coll Cardiol, 52, 1402, 10.1016/j.jacc.2008.06.046 St John Sutton, 2003, Effect of cardiac resynchronization on LV size and function in chronic heat failure, Circulation, 107, 1985, 10.1161/01.CIR.0000065226.24159.E9 Duncan, 2003, Eur Heart J, 24, 430, 10.1016/S0195-668X(02)00475-X Saxon, 2002, Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling, Circulation, 105, 1304, 10.1161/hc1102.105730 Reuter, 2002, Comparison of characteristics in responders versus non-responders with biventricular pacing for drug–resistant congestive heart failure, Am J Cardiol, 89, 346, 10.1016/S0002-9149(01)02240-8 Díaz-Infante, 2005, Predictors of lack of response to resynchronization therapy, Am J Cardiol, 95, 1436, 10.1016/j.amjcard.2005.02.009 Cabrera Bueno, 2007, Repercussion of functional mitral regurgitation on reverse remodeling in cardiac resynchronization therapy, Europace, 9, 757, 10.1093/europace/eum122 Yu, 2002, Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure, Circulation, 105, 438, 10.1161/hc0402.102623 Stellbrink, 2001, Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances, J Am Coll Cardiol, 38, 1957, 10.1016/S0735-1097(01)01637-0 Vidal, 2006, Relation of response to cardiac resynchronization therapy to left ventricular reverse remodeling, Am J Cardiol, 97, 876, 10.1016/j.amjcard.2005.09.137 Opasich, 2001, Six-minute walking performance in patients with moderate-to-severe heart failure. Is it a useful indicator in clinica practice?, Eur Heart J, 22, 488, 10.1053/euhj.2000.2310 Poole-Wilson, 2003, Comparison of carvedilol and metoprolol on clinical outcomes in patients with cronic heart failure in the Carvedilol Or Metoprolol Euopean Trial (COMET): Randomized controlled trial, Lancet, 362, 7, 10.1016/S0140-6736(03)13800-7 The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316:1429–5.